Novel Formulation Strategies

“Novel Formulation Strategies” is a unique, Pharma Industry focused, event designed to discuss novel strategies for pharmaceutical product development. India is the largest manufacturer of generic medicines globally and therefore drug formulation strategies need to be updated and discussed in order to successfully develop novel formulations. This event will include discussions by Pharma Industry Experts covering issues like Solubility & Oral Bioavailability Enhancement, Modified Release Formulations, Difficult to Formulate FDC, Water Insoluble drugs and 505(b)2 – Innovations for US market. The organizers envisage to bring more and more overseas and industry scientists as speakers.

Academic Innovation Session: In this event a special session has been designated towards Academic Innovations. A large number of Pharmaceutical Scientists in Academic Institutions have been working on formulation development. In this session we aim to present selected Academic Formulation related Innovations which might have importance in industry but could otherwise go unnoticed by industry scientists. This session will be open to Regular PhD Research Scholars only. Each presentation will be for 5-10 minutes duration only and will be adjudged by the industry scientists. The presentation providing best innovation and/or solution with direct application in pharmaceutical industry will be awarded Rs 5100/-during the closing ceremony of the conference. In addition the 2nd and 3rd position presentations will be awarded Rs 3100/- and Rs 2100/- respectively. Faculty (Registered Indian Delegate) presenting the innovation will not be eligible for the award but will be allowed to present.

The last date for submission of abstract for presentation in this session is upto January 31, 2018. The selected abstracts will be intimated latest by February 15, 2018. The selected presenters will be required to complete the registration process latest by March 1, 2018. Those not registering by the said date will loose the opportunity to present and the same will be offered to the next candidate.

Who Should Attend: Pharmaceutical Industry Scientists working in Formulation R & D or Product Development, Technology Transfer & Novel Drug Delivery Systems, Technical Experts in Pharmaceutical Manufacturing and Experts in Pharmaceutical Business Development